洲明科技(300232.SZ):實控人林洺鋒倡議增持股票事項已實施完畢
格隆匯11月30日丨洲明科技(300232.SZ)公佈,根據倡議書披露的具體實施細則約定:“補償金額=增持期間淨買入數量*(增持期間淨買入股票均價-截至2021年11月15日後10個交易日股票均價)”,公司2021年11月16日至2021年11月29日,股票均價為9.35元/股,不僅高於增持期間淨買入股票均價,也高於增持期間股票最高價。上述參與增持公司股票並持有18個月以上的員工均處於盈利狀態,未產生虧損。
按照公司控股股東、實際控制人林洺鋒承諾約定的條件,林洺鋒無需向參與增持公司股票的員工進行補償。因此,公司控股股東、實際控制人林洺鋒倡議增持股票事項已實施完畢,相關承諾事項已履行完畢。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.